SEC Form 4 · accession 0001144204-17-022289
Moleculin Biotech, Inc. · MBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan P. Foster
Officer — Exec. Vice President & CFO
Period of report
Apr 25, 2017
Accepted (ET)
Apr 26, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659617
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2017 | P | 10,000 | $0.8649 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.